Primo Medical Group, headquartered in Massachusetts and renowned for its expertise in crafting high-quality medical devices and precision-machined custom components, has unveiled the establishment of their seventh startup venture. Named Trax Surgical LLC, this company specializes in orthopedic product development and distribution, with a primary focus on catering to the orthopedic extremities market.

Notably, Trax Surgical has recently obtained FDA 510(k) clearance to introduce the TRAX Compression Screw System into the market. This innovative system offers a comprehensive array of bone screws designed for various orthopedic procedures, including osteotomy, fixation, fusion, and fracture treatments. The TRAX Compression Screw System comprises both headed and non-headed titanium screws. Each of these cannulated, self-tapping screws is available in diameters ranging from 2.0mm to 6.5mm, along with a choice of lengths spanning from 12.0mm to 110.0mm. Additionally, a set of non-cannulated, headed snap-off screws can be acquired in 2.0mm diameter, with four available lengths ranging from 11.0mm to 14.0mm.

In a significant development, Trax Surgical is actively working on the creation of an orthopedic compression staple constructed from Nitinol. This staple harnesses inherent compressive properties, fostering a stable fracture environment that encourages primary bone healing. Bone staples offer a crucial intraoperative advantage due to their simplified and quicker application, necessitating fewer procedural steps. This stands as a valuable option for surgeons as they assess the specific needs of their patients. Trax Surgical anticipates the launch of its compression staple in the third quarter of 2024.

Source: prnewswire.com